生物医学倫理:歴史的・哲学的考察<br>Historical and Philosophical Perspectives on Biomedical Ethics : From Paternalism to Autonomy? (Ashgate Studies in Applied Ethics)

生物医学倫理:歴史的・哲学的考察
Historical and Philosophical Perspectives on Biomedical Ethics : From Paternalism to Autonomy? (Ashgate Studies in Applied Ethics)

  • ただいまウェブストアではご注文を受け付けておりません。 ⇒古書を探す
  • 製本 Hardcover:ハードカバー版/ページ数 159 p.
  • 言語 ENG
  • 商品コード 9780754615293
  • DDC分類 174.2

基本説明

Addresses the question of a historic change from medical paternalism to patient autonomy in matters of health.

Full Description


This volume discusses the subject of biomedical ethics. Various views, historical and contemporary, are discussed, with the editors using the contrasting concepts in the shift from paternalism to autonomy in 20th-century medicine as a heuristic tool for the critical study of ethics in medicine.As far as the evidence in this volume goes, paternalistic medical practices and patient autonomy had an uneasy relationship by the beginning of the 20th century. A hundred years later, full autonomy in decisions on medical treatment is still subject to numerous caveats. The text pays close attention to the interplay between various players, noting how factors such as social contexts, governmental organizations and the biotechnological industry influence and shape responses to the principle of bioethics.

Contents

Introduction, Andreas-Holger Maehle and Johanna Geyer-Kordesch; "honour and interests" - medical ethics and the British Medical Association, Andrew A.G. Morrice; the emergence of medical professional ethics in Germany, Andreas-Holger Maehle; health costs and the ethics of the German sickness insurance system, Lutz D.H. Sauerteig; problems of consent to surgical procedures and autopsies in 20th-century Germany, Cay-Rudiger Prull and Marianne Sinn; human research - from ethos to law, from national to international regulations, Ulrich Trohler; ethical aspects of life-saving and life-sustaining technologies, Bryan Jennett; autonomous agency and consent in the treatment of the terminally ill, Susan L. Lowe; the "Frankenstein" nature of biotechnology, David E. Cooper.